Back

Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Atrial fibrillation - Stroke prevention Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Amol Dhamane

Bristol-Myers Squibb, Lawrenceville (United States of America)

27 More presentations in this session

Presentation thumbnail
The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis.
Professor P. Penson (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Net clinical benefit of NOACs vs. VKAs in elderly patients with atrial fibrillation: a pooled analysis from the real-world PREFER in AF and PREFER in AF PROLONGATION registries
Doctor I. Cavallari (Rome, IT)
Abstract Slides
Presentation thumbnail
A meta-analysis of efficacy and safety of Watchman device for left atrial appendage closure in non-valvular atrial fibrillation
Doctor A. Jhand (Omaha, US)
Abstract Slides
Presentation thumbnail
A metaanlysis for safety and efficacy of amplatzer cardiac plug and amulet device for left atrial appendage closure in patiets with non valvular atrial fibrillation
Doctor A. Thandra (Omaha, US)
Abstract Slides
Presentation thumbnail
Use of oral anticoagulation is less among hospitalized patients with paroxysmal compared to persistent or permanent atrial fibrillation
Doctor S. Pokorney (Durham, US)

Access the full session

Session thumbnail
Poster Session 4 - Atrial fibrillation - Stroke prevention

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources